Quality of life in good prognosis patients with metastatic germ cell cancer: a prospective study of the European Organization for Research and Treatment of Cancer Genitourinary Group/Medical Research Council Testicular Cancer Study Group (30941/TE20).
暂无分享,去创建一个
L. Collette | S. Fosså | N. Aaronson | A. Bottomley | P. Wilkinson | P. D. De Mulder | R. de Wit | G. Mead | S. Stenning | P. Cook | J. Roberts | L. de Prijck | G. Mead | S. D. Fosså | S. Fosså
[1] S. Fosså,et al. Patients' and doctors' perception of long-term morbidity in patients with testicular cancer clinical stage I , 2005, Supportive Care in Cancer.
[2] N. Aaronson,et al. The European Organization for Research and treatment of cancer approach to quality of life assessment: guidelines for developing questionnaire modules , 1993, Quality of Life Research.
[3] S. Rodenhuis,et al. Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.
[4] F. Joly,et al. Quality of life in long-term survivors of testicular cancer: a population-based case-control study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] L. Collette,et al. Flutamide versus prednisone in patients with prostate cancer symptomatically progressing after androgen-ablative therapy: a phase III study of the European organization for research and treatment of cancer genitourinary group. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] K. Wikblad,et al. Health-Related Quality of Life in Survivors of Testicular Cancer 3 to 13 Years After Treatment , 2000 .
[7] L. Weissbach,et al. RPLND or Primary Chemotherapy in Clinical Stage IIA/B Nonseminomatous Germ Cell Tumors? , 2000, European Urology.
[8] N. Aaronson,et al. Quality of life after palliative radiotherapy in non-small cell lung cancer: a prospective study. , 2000, International journal of radiation oncology, biology, physics.
[9] S. Fosså,et al. Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection , 1999, British Journal of Cancer.
[10] R. Stephens,et al. Patient-reported short-term and long-term physical and psychologic symptoms: results of the continuous hyperfractionated accelerated [correction of acclerated] radiotherapy (CHART) randomized trial in non-small-cell lung cancer. CHART Steering Committee. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] E. Small,et al. Long-term side effects of treatment for testis cancer. , 1998, The Urologic clinics of North America.
[12] H. Ozen,et al. Psychosocial adjustment after testicular cancer treatment. , 1998, The Journal of urology.
[13] C. Gotay,et al. Quality of life in long-term survivors of adult-onset cancers. , 1998, Journal of the National Cancer Institute.
[14] D. Osoba,et al. Interpreting the significance of changes in health-related quality-of-life scores. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] H. Hoekstra,et al. Sexual functioning after treatment for testicular cancer , 1997, Cancer.
[16] P. Hilkens,et al. Chemotherapy-induced peripheral neuropathy. , 1997, Journal of the peripheral nervous system : JPNS.
[17] C. Bokemeyer,et al. Evaluation of long-term toxicity after chemotherapy for testicular cancer. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] T. Terachi,et al. Psychosocial aspects in long-term survivors of testicular cancer. , 1996, The Journal of urology.
[19] A. Varghese,et al. Psychosocial outcomes of cancer: a comparative analysis of Hodgkin's disease and testicular cancer. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] D. Osoba,et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.
[21] D. Tulsky,et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] A. Varghese,et al. Changes in marital and sexual functioning in long‐term survivors and their spouses: Testicular cancer versus hodgkin's disease , 1992 .
[23] S. Fosså,et al. Psychosocial well-being in testicular cancer patients. , 1991, European Journal of Cancer.
[24] J. de Haes,et al. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. , 1990, British Journal of Cancer.
[25] S. Fosså,et al. Long-term somatic side-effects and morbidity in testicular cancer patients. , 1990, British Journal of Cancer.
[26] J. Landsverk,et al. Long‐term effects of testicular cancer on sexual functioning in married couples , 1989, Cancer.
[27] J. Landsverk,et al. Psychosocial Sequelae in Long-Term Survivors of Testicular Cancer , 1989 .
[28] Blair Rl,et al. A review of cis-platinum ototoxicity. , 1983 .
[29] H. Pinedo,et al. Ototoxicity of cis-diamminedichloroplatinum (II): influence of dose, schedule and mode of administration. , 1983, European journal of cancer & clinical oncology.